NCT01620450View on ClinicalTrials.gov

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese

PHASE1CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

November 20, 2004

Primary Completion Date

February 26, 2005

Study Completion Date

February 26, 2005

Conditions

DiabetesHealthy

Interventions

DRUG

biphasic human insulin 30

Single dose of each formulation administered subcutaneously (s.c., under the skin) on two separate visits

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT01620450 - Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese | Biotech Hunter | Biotech Hunter